NordicTrack’s Most Ambitious Pilates Machine Yet: Introducing the Ultra 1 Reformer
19.5.2026 15:00:00 CEST | Business Wire | Press Release
NordicTrack is bringing studio-grade Pilates directly into the home with the Ultra 1 Reformer, available to order May 19 at NordicTrack.com for $US4,999. Blending luxury craftsmanship with smart technology, this consumer-focused model offers a studio‐quality Pilates experience that fits effortlessly into modern living.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519139005/en/
NordicTrack Ultra 1 Reformer
Pilates has become a cornerstone of modern wellness, recognized for building core strength, improving flexibility, and fostering a deep mind-body connection. Recognizing this growing demand, NordicTrack’s new reformer pairs elegant design with an integrated HD touchscreen and seamless access to expert‐led classes through the iFIT platform.
“The Ultra 1 Reformer is the first Pilates machine that earns its place in your home. Real equipment, personalized expert instruction, and the results we are all seeking,” says Kevin Duffy, CEO of iFIT Inc.
“The Ultra 1 Reformer does something no other machine has done — it removes the intimidation and complexity that can come with reformer Pilates, creating a genuine, studio-quality experience at home that feels intuitive and immersive,” says Yvette McGaffin, Director of Product Marketing, Pilates at iFIT. “From the Smart Spine system to push-button resistance and real-time feedback, every detail was built so the only thing you’re thinking about is your workout.”
A Smarter, Safer Way to Move at Home Pulling design elements from NordicTrack’s award winning Ultra 1 Treadmill, the Ultra 1 Reformer was specifically engineered to elevate home wellness spaces. It features a warm maple finish that blends naturally into contemporary homes. To prioritize ease of use and safety, the Ultra 1 Reformer introduces several innovative design elements:
- Smart Spine™ System: This first-of-its-kind system features an enclosed spring design, eliminating exposed springs for a cleaner look and added safety, which is ideal for homes with children or pets.
- Push-Button Resistance Adjustment: Users can easily adjust spring tension with a simple press or lift of a button, eliminating the need to manually hook springs.
- Tailored Resistance: The system utilizes 3 buttons to deliver 7 distinct resistance levels ranging from 22 to 99 lbs (10-45 kg).
- Immersive HD Touchscreen: The reformer is equipped with a 24-inch (61 cm) HD touchscreen that tilts, pivots, and swivels to the left side, powered by the iFIT OS for seamless content delivery.
- Adjustable Footbar: Features 4 adjustable positions and 2 cane-shaped footbars to accommodate various movements and user sizes.
Connected Pilates, Anytime Powered by iFIT, members gain instant access to a growing library of 75+ reformer-specific programs and over 200 mat Pilates workouts led by expert instructors. The machine provides real-time on-screen feedback to guide resistance levels and track performance, ensuring users keep up with instructors on-screen. The Ultra 1 Reformer is available to order starting May 19 at NordicTrack.com for $4,999. Additional accessories — including a Jumpboard, Pilates Box, and Reformer Mat — are available separately.
About iFIT iFIT Inc. is a global leader in fitness technology, pioneering connected fitness to help people live longer, healthier lives. With a community of more than 12 million athletes around the world, iFIT delivers immersive, personalized workout experiences at-home, on the go, and in the gym. Powered by a comprehensive ecosystem of proprietary software, innovative hardware, and engaging content, the iFIT platform brings fitness to life through its portfolio of brands: NordicTrack, ProForm, Freemotion, and the iFIT app. From cardio and strength training to recovery, iFIT empowers athletes at every stage of their fitness journey. For more information, visit iFIT.com.
About NordicTrack: NordicTrack, a brand of iFIT Inc., has been a pioneer in connected home fitness for over 50 years. From treadmills and bikes to strength and Pilates, NordicTrack combines premium hardware with the iFIT platform to deliver personalized, expert-led experiences that meet members wherever they are in their fitness journey. For more information, visit NordicTrack.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260519139005/en/
Contacts
Media Contact:
Edelman for iFIT Inc.
iFIT@edelman.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press Release
Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integration, Black Recon allows crews to launch, operate, recover, and recharge up to three unmanned aerial systems without leaving their platform, reducing risk and accelerating decision-making. “Black Recon
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press Release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press Release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom